Mette Bach Larsen,1 Hans Svanholm,1,2 Berit Andersen1 1Department of Public Health Programmes, 2Department of Pathology, Randers Regional Hospital, Randers, Denmark Introduction: In Denmark, an organized approach to cervical cancer screening has had national coverage since 1998. However, in 2013, it was discovered that 19,000 females had been unsubscribed from the Danish National Cervical Cancer Screening Program and had thus not received invitations or reminders as recommended by the health authorities. The study aims to report the essence of this adverse event and describe the outcomes of reestablishing invitations in terms of participation rates and screening results. Furthermore, patient compensations to affected females diagnosed with ...
Item does not contain fulltextBACKGROUND: This study aims to examine the impact of women's character...
We studied harms related to cervical cancer screening and management of screen-positive women in the...
Cervical cancer is the fourth most common reason for cancer death amongst women worldwide, with 500 ...
Population based cervical cancer screening (CCS), performed by midwives, to detect cellularatypia be...
OBJECTIVE: The objective of the study was to assess the screening history of women with cervical can...
Introduction: In Norway, all patient-reported claims for compensation are evaluated by The Norwegian...
Our study used a refined case-control cervical cancer Audit framework to investigate effectiveness o...
Introduction: In Norway, all patient-reported claims for compensation are evaluated by The Norwegian...
Item does not contain fulltextOBJECTIVE: The objective of the study was to assess the screening hist...
Declining attendance in the Dutch cervical cancer screening programme was recently observed, coincid...
Declining attendance in the Dutch cervical cancer screening programme was recently observed, coincid...
Cervical cancer is the second most common type of cancer among women worldwide. In Sweden cervical c...
Cervical cancer is the second most common type of cancer among women worldwide. In Sweden cervical c...
We studied harms related to cervical cancer screening and management of screen-positive women in the...
Women afflicted with cervical cancer who have the highest morbidity and mortality rates have been th...
Item does not contain fulltextBACKGROUND: This study aims to examine the impact of women's character...
We studied harms related to cervical cancer screening and management of screen-positive women in the...
Cervical cancer is the fourth most common reason for cancer death amongst women worldwide, with 500 ...
Population based cervical cancer screening (CCS), performed by midwives, to detect cellularatypia be...
OBJECTIVE: The objective of the study was to assess the screening history of women with cervical can...
Introduction: In Norway, all patient-reported claims for compensation are evaluated by The Norwegian...
Our study used a refined case-control cervical cancer Audit framework to investigate effectiveness o...
Introduction: In Norway, all patient-reported claims for compensation are evaluated by The Norwegian...
Item does not contain fulltextOBJECTIVE: The objective of the study was to assess the screening hist...
Declining attendance in the Dutch cervical cancer screening programme was recently observed, coincid...
Declining attendance in the Dutch cervical cancer screening programme was recently observed, coincid...
Cervical cancer is the second most common type of cancer among women worldwide. In Sweden cervical c...
Cervical cancer is the second most common type of cancer among women worldwide. In Sweden cervical c...
We studied harms related to cervical cancer screening and management of screen-positive women in the...
Women afflicted with cervical cancer who have the highest morbidity and mortality rates have been th...
Item does not contain fulltextBACKGROUND: This study aims to examine the impact of women's character...
We studied harms related to cervical cancer screening and management of screen-positive women in the...
Cervical cancer is the fourth most common reason for cancer death amongst women worldwide, with 500 ...